AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
59,100
-5,500 (-8.51%)
At close: Feb 6, 2026
266.85%
Market Cap1.38T +273.8%
Revenue (ttm)8.97B -56.7%
Net Income-877.63M
EPS-39.00
Shares Out23.34M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume511,693
Average Volume538,466
Open61,000
Previous Close64,600
Day's Range56,600 - 62,800
52-Week Range11,980 - 66,700
Beta1.57
RSI58.68
Earnings Daten/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements